Product reference notes for new serological assays to diagnose SARS-CoV-2

New serological assays for detection of SARS-CoV-2 infection are added to UNICEF Supply Catalogue.

About

New serological assays, rapid antigen (Ag) tests for COVID-19 diagnosis have been added to the UNICEF diagnostics portfolio and are now available for UNICEF programme countries and procurement services partners in addition to manual and automated real-time PCR tests. Like all other COVID-19 diagnostics procured by Supply Division, new products are quality-assured, i.e. either listed under the WHO Emergency Use List (EUL) or holding the FDA Emergency Use Authorization (EUA).

The new rapid antigen diagnostic tests for COVID-19 diagnosis are available with very short FCA lead times, which is critical for countries struggling with COVID-19 supply shortages and interruptions. More rapid antigen diagnostic tests will be added as they become available.

Product reference notes for all new COVID-19 diagnostics are available and useful for evaluators and decision-makers. The notes include comprehensive technical and commercial information, such as kit contents, storage conditions, as well as price and indicative lead time.

Download document

(PDF, 183,13 KB) (PDF, 72,86 KB) (PDF, 58,97 KB)